RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

Clinical trial NCT07489651 · RECRUITING

Trial details

NCT number: NCT07489651
Sponsor: Reunion Neuroscience Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2026-04-20
Primary completion: 2027-02-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.